Sunday, September 27, 2026

Arena Pharmaceuticals Stock Is 4% Up So Far Today

ViaNews Editorial Team

December 8, 2020

Arena Pharmaceuticals Stock Is 4% Up So Far Today

Shares of Arena Pharmaceuticals jumped 4.42% to $69.70 at 14:05 EST on Tuesday, following yesterday's downward trend. The Nasdaq Stock Market is jumping 0.32% to $12,559.50, after three successive sessions in a row of gains, on what up to now seems, a somewhat positive trend trading session today.

Arena Pharmaceuticals's last close was $66.75, 29.40% under its 52-week high of $90.19.

Arena Pharmaceuticals's Sales

Arena Pharmaceuticals's sales growth is a negative 81.3% for the ongoing quarter and 155.7% for the next. The company's growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals's Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals's Stock Top and Bottom Yearly Value

Arena Pharmaceuticals's stock is valued at $69.70 at 14:05 EST, way below its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals's Moving Average

Arena Pharmaceuticals's value is below its 50-day moving average of $73.92 and above its 200-day moving average of $68.94.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Vertical AI Agents Attract a Funding Wave Across Fintech-Adjacent Industries
A cluster of AI-native startups applying autonomous agents to narrow, operational problems — hotel front-desk staffing (Dextr AI), identity/fraud risk for financial institutions (Baselayer), insurance distribution (Napo, Connie Health, MGT Insurance) — closed seed-to-Series A rounds within days of each other in September 2026, with CB Insights running a coordinated CEO interview series to spotlight them. The pattern points to agentic AI maturing from generic chat tools into vertical, revenue-generating products, with identity verification for AI agents themselves (Baselayer) emerging as a new fintech infrastructure category responding directly to AI-driven fraud risk.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com